Bruker
Division of Bruker Corporation providing X-ray diffraction (XRD), X-ray fluorescence (XRF), and micro-CT instruments for material characterization and non-destructive quality control of additive manufacturing parts.
- CEO / Founder
- Frank H. Laukien
- Team Size
- 501-1000
- Stage
- Subsidiary
- Total Funding
- Undisclosed
- Latest Round
- IPO
- Key Investors
- Public Market, Bruker Daltonics
Technology & Products
Key Products
SkyScan 2214 Multi-Scale X-ray Nano-CT; D8 ADVANCE X-ray Diffractometer; S8 TIGER Series 2 XRF Spectrometer; G6 LEONARDO ONH Analyzer; DIFFRAC.SUITE software
Technological Advantage
Proprietary high-flux X-ray sources and advanced reconstruction algorithms enable 3D defect detection at speeds suitable for industrial quality control. Unique combination of XRD for residual stress, XRF for powder chemistry, and micro-CT for internal defect detection.
Differentiation
Value Proposition
Reduces scrap rates and ensures structural integrity of mission-critical AM parts by providing sub-micron resolution 3D inspection of internal porosities, residual stress, and powder quality via integrated XRD, XRF, and micro-CT workflows.
How They Differentiate
Bruker differentiates itself through technological innovation, product breadth, and customer support, offering a holistic suite of instruments for comprehensive materials characterization.
Market & Competition
Target Customers
Aerospace OEMs, medical device manufacturers, automotive engineering firms, energy sector, and AM research laboratories requiring non-destructive material characterization.
Industry Verticals
Aerospace; Medical; Automotive; Energy; Academia
Competitors
Waygate Technologies (Baker Hughes); Nikon Metrology; ZEISS Industrial Quality Solutions; Rigaku
Growth & Milestones
Growth Metrics
Bruker Corporation reported 2025 revenue of $3.44B, expecting $3.57-3.60B in 2026 (IR 2026). BSI scientific instruments segment consistent YoY growth; 501-1000 employees at AXS division; global presence in 100+ countries. Recent acquisitions: NanoString (2024), Biocrates (2025), TOFWERK remaining 60% (2026).
Major Milestones
1997: Bruker AXS GmbH founded in Karlsruhe; 2008: Merged into Bruker Corporation (NASDAQ: BRKR); 2012: Acquisition of SkyScan to bolster micro-CT; 2019: Launch of SkyScan 2214 for high-resolution AM inspection; 2024-07-11: SE conversion under German corporate law (HRB 751520); 2024: Acquisition of NanoString business; 2025: Acquisition of Biocrates; 2026: Consolidated ownership of TOFWERK (remaining 60%)
Notable Customers
NASA; Boeing; Siemens Energy; ETH Zurich; Airbus